
    
      The total study duration per patient will have a minimum 12 weeks and maximum 22 weeks (up to
      2 weeks screening period + 8-12 weeks pre-Ramadan period + 29-30 days Ramadan + 0 4 weeks
      post-Ramadan period). This is a phase 3b study in Kingdom of Saudi Arabia and Bangladesh
      (instead of phase 4 for other countries).
    
  